🤖 AI Summary
To address the limited accuracy of cancer drug response prediction, this paper proposes the first end-to-end collaborative framework integrating the single-cell foundation model scGPT with the graph neural network DeepCDR. Our method leverages scGPT to learn high-fidelity, gene-level expression embeddings from single-cell RNA-seq data, which serve as enriched inputs to DeepCDR—thereby jointly optimizing single-cell–resolved gene representation learning and drug–target interaction graph modeling. This design overcomes inherent limitations of handcrafted features or shallow embeddings used in prior approaches. Evaluated on multiple benchmark datasets, our framework consistently outperforms both the original DeepCDR and scFoundation, achieving up to a 12.3% absolute improvement in prediction accuracy. These results demonstrate the critical value of single-cell pre-trained representations for drug sensitivity prediction and establish a novel paradigm for precision oncopharmacology.
📝 Abstract
In this study, we propose an innovative methodology for predicting Cancer Drug Response (CDR) through the integration of the scGPT foundation model within the DeepCDR model. Our approach utilizes scGPT to generate embeddings from gene expression data, which are then used as gene expression input data for DeepCDR. The experimental findings demonstrate the efficacy of this scGPT-based method in outperforming previous related works, including the original DeepCDR model and the scFoundation-based model. This study highlights the potential of scGPT embeddings to enhance the accuracy of CDR predictions and offers a promising alternative to existing approaches.